Probiyotikler ve Periodontal Sağlık

Yıl 2022, Cilt: 9 Sayı: 2, 706 - 712, 24.08.2022

Dilek Biçer Gülsüm Dal Didem Özkal Eminoğlu

https://doi.org/10.15311/selcukdentj.956715

Cited By: 1

Öz

Dünya sağlık örgütü (WHO) ve Amerika Gıda ve Tarım Örgütü (FAO) ‘nün probiyotik bakteri tanımı şöyledir; uygun miktarlarda kullanıldıklarında sağlık için faydalı etkileri olan yaşayan mikroorganizmalardır. Periodontal hastalıklar, dişetinde başlayan enfeksiyonun dişeti bağ dokusu, periodontal ligament ve alveol kemiğine ulaşmasıyla dişin periodonsiyumunda yıkıma neden olarak dişlerde mobilite ve ardından diş kaybına sebep olan, kronik enfamatuvar hastalıklardır. Periodontal tedavide klasik mekanik uygulamalar, dentin kanallarındaki, konkavitelerdeki ve yumuşak dokuya invaze olmuş bakterileri elimine etmekte yeterli olmamaktadır. Bu nedenle mekanik temizliğe ek olarak kullanılan antimikrobiyal ajanlar periodontopatojenleri azaltmaya katkıda bulunur. Bazı araştırmalar sonucunda probiyotikler gündeme gelmeye başlamıştır. Günümüzde yapılan pek çok araştırmada canlı bakterilerin tedavi amacıyla kullanılması ön plana çıkmaktadır.

Anahtar Kelimeler

probiyotik, periodontal tedavi, mikroorganizma

Kaynakça

• 1. Brown AC, Valiere A. Probiotics and medical nutrition therapy. Nutrition in clinical care: an official publication of Tufts University. 2004;7(2):56.
• 2. Yeşilova Y SB, Yavuz E, Uçmak D. Probiyotikler. J Kartal TR. 2010;21:7.
• 3. Meurman JH, Stamatova I. Probiotics: contributions to oral health. Oral diseases. 2007;13(5):443-51.
• 4. Kinane D, Attström R. Advances in the pathogenesis of periodontitis. Group B consensus report of the fifth European Workshop in Periodontology. Journal of Clinical Periodontology. 2005;32:130-1.
• 5. Otomo-Corgel J, Pucher JJ, Rethman MP, Reynolds MA. State of the science: chronic periodontitis and systemic health. Journal of Evidence Based Dental Practice. 2012;12(3):20-8.
• 6. Demmer R, Papapanou PN. Epidemiologic patterns of chronic and aggressive periodontitis. Periodontology 2000. 2010;53:28.
• 7. Marsh PD. Dental plaque: biological significance of a biofilm and community life‐style. Journal of clinical periodontology. 2005;32:7-15.
• 8. Foster JS, Kolenbrander PE. Development of a multispecies oral bacterial community in a saliva-conditioned flow cell. Applied and environmental microbiology. 2004;70(7):4340-8.
• 9. Mandel ID, Gaffar A. Calculus revisited: a review. Journal of clinical periodontology. 1986;13(4):249-57.
• 10. Slots J. Periodontology: past, present, perspectives. Periodontology 2000. 2013;62(1):7-19.
• 11. Tan BT, Mordan NJ, Embleton J, Pratten J, Galgut PN. Study of bacterial viability within human supragingival dental calculus. Journal of periodontology. 2004;75(1):23-9.
• 12. Moolya NN, Thakur S, Ravindra S, Setty SB, Kulkarni R, Hallikeri K. Viability of bacteria in dental calculus–A microbiological study. Journal of Indian Society of Periodontology. 2010;14(4):222.
• 13. Ishikawa I, Baehni P. Nonsurgical periodontal therapy–where do we stand now? Periodontology 2000. 2004;36(1):9-13.
• 14. Newman MG TH, Klokkvold PR, Carranza FA. . Carranza's Clinical Periodontology. 11 ed2012.
• 15. Plessas A. Nonsurgical periodontal treatment: review of the evidence. Oral Health Dent Manag. 2014;13(1):71-80.
• 16. Quirynen M, Teughels W, SOETE MD, STEENBERGHE DV. Topical antiseptics and antibiotics in the initial therapy of chronic adult periodontitis: microbiological aspects. Periodontology 2000. 2002;28(1):72-90.
• 17. Hanes PJ, Purvis JP. Local anti‐infective therapy: Pharmacological agents. A systematic review. Annals of Periodontology. 2003;8(1):79-98.
• 18. Özener HÖ, Bahar E. Probiyotiklerin periodontal tedavideki yeri. Clinical and Experimental Health Sciences. 2015;5(1):53-64.
• 19. Coşkun T. Pro-, pre-ve sinbiyotikler. çocuk sağlığı ve hastalıkları dergisi. 2006;49(2):128-48.
• 20. Kaleli İ. Probiyotiklerin etki mekanizması. Antibiyotik ve Kemoterapi Derneği Dergisi. 2007;21(2):238-42.
• 21. Otles S, Cagindi O, Akcicek E. Probiotics and health. Asian Pacific Journal of Cancer Prevention. 2003;4(4):369-72.
• 22. Isolauri E, da Costa Ribeiro H, Gibson G, Saavedra J, Saliminen S, Vanderhoof J, et al. Functional foods and probiotics: Working group report of the first world congress of pediatric gastroenterology, hepatology, and nutrition. Journal of pediatric gastroenterology and nutrition. 2002;35:S106-S9. 23. Gürsoy O, Kınık Ö, Gönen İ. Probiyotikler ve gastrointestinal sağlığa etkileri. Türk Mikrobiyoloji Cemiyeti Dergisi. 2005;35(2):136-48.
• 24. Vasiljevic T, Shah NP. Probiotics—from Metchnikoff to bioactives. International Dairy Journal. 2008;18(7):714-28.
• 25. Billoo AG, Memon M, Khaskheli S, Murtaza G, Iqbal K, Shekhani MS, et al. Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World journal of gastroenterology: WJG. 2006;12(28):4557.
• 26. Kim H-S, Park H, Cho I-Y, Paik H-D, Park E. Dietary supplementation of probiotic Bacillus polyfermenticus, Bispan strain, modulates natural killer cell and T cell subset populations and immunoglobulin G levels in human subjects. Journal of medicinal food. 2006;9(3):321-7.
• 27. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. Probiotics and immunity. Journal of gastroenterology. 2009;44(1):26-46.
• 28. Salminen S, Deighton M, Gorbach S. Lactic acid bacteria in health and disease: Marcel Dekker Inc.; 1993.
• 29. Gupta V, Garg R. Probiotics. Indian journal of medical microbiology. 2009;27(3):202.
• 30. Ewaschuk JB, Dieleman LA. Probiotics and prebiotics in chronic inflammatory bowel diseases. World journal of gastroenterology: WJG. 2006;12(37):5941.
• 31. Lebeer S, Claes IJ, Verhoeven TL, Vanderleyden J, De Keersmaecker SC. Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine. Microbial biotechnology. 2011;4(3):368-74.
• 32. Sarkar S. Probiotics as functional foods: gut colonization and safety concerns. Nutrition & Food Science. 2013.
• 33. Nagpal R, Yadav H, Kumar M, Jain S, Yamashiro Y, Marotta F. Probiotics, Prebiotics and Synbiotics: An Introduction. Probiotics and Prebiotics in Food, Nutrition and Health. 2013:1.
• 34. Başyiğit G, Karahan AG, Kılıç B. Fermente et ürünlerinde fonksiyonel starter kültürler ve probiyotikler. Türk Hijyen ve Deneysel Biyoloji Dergisi. 2007;64(2):60-9.
• 35. Kleerebezem M, Binda S, Bron PA, Gross G, Hill C, van Hylckama Vlieg JE, et al. Understanding mode of action can drive the translational pipeline towards more reliable health benefits for probiotics. Current Opinion in Biotechnology. 2019;56:55-60.
• 36. Työppönen S, Petäjä E, Mattila-Sandholm T. Bioprotectives and probiotics for dry sausages. International Journal of Food Microbiology. 2003;83(3):233-44.
• 37. Kantarci A, Hasturk H, Van Dyke TE. Host‐mediated resolution of inflammation in periodontal diseases. Periodontology 2000. 2006;40(1):144-63.
• 38. Berezow AB, Darveau RP. Microbial shift and periodontitis. Periodontology 2000. 2011;55(1):36.
• 39. Chatterjee A, Bhattacharya H, Kandwal A. Probiotics in periodontal health and disease. Journal of Indian society of periodontology. 2011;15(1):23.
• 40. Kõll‐Klais P, Mändar R, Leibur E, Marcotte H, Hammarström L, Mikelsaar M. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral microbiology and immunology. 2005;20(6):354-61.
• 41. Krasse P, Carlsson B, Dahl C, Paulsson A, Nilsson A, Sinkiewicz G. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swedish dental journal. 2006;30(2):55-60.
• 42. Kim H-S, Kim Y-Y, Oh J-K, Bae K-H. Is yogurt intake associated with periodontitis due to calcium? PloS one. 2017;12(10):e0187258.
• 43. Sookkhee S, Chulasiri M, Prachyabrued W. Lactic acid bacteria from healthy oral cavity of Thai volunteers: inhibition of oral pathogens. Journal of applied microbiology. 2001;90(2):172-9.
• 44. Mayanagi G, Kimura M, Nakaya S, Hirata H, Sakamoto M, Benno Y, et al. Probiotic effects of orally administered Lactobacillus salivarius WB21‐containing tablets on periodontopathic bacteria: a double‐blinded, placebo‐controlled, randomized clinical trial. Journal of clinical periodontology. 2009;36(6):506-13.
• 45. Peña JA, Rogers AB, Ge Z, Ng V, Li SY, Fox JG, et al. Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infection and immunity. 2005;73(2):912-20.
• 46. Szkaradkiewicz AK, Stopa J, Karpiński TM. Effect of oral administration involving a probiotic strain of Lactobacillus reuteri on pro-inflammatory cytokine response in patients with chronic periodontitis. Archivum immunologiae et therapiae experimentalis. 2014;62(6):495-500.
• 47. Twetman S, Derawi B, Keller M, Ekstrand K, Yucel-Lindberg T, Stecksen-Blicks C. Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid. Acta Odontologica Scandinavica. 2009;67(1):19-24.
• 48. Teughels W, Durukan A, Ozcelik O, Pauwels M, Quirynen M, Haytac MC. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo‐controlled study. Journal of clinical periodontology. 2013;40(11):1025-35.
• 49. İnce G, Gürsoy H, İpçi ŞD, Cakar G, Emekli‐Alturfan E, Yılmaz S. Clinical and biochemical evaluation of lozenges containing Lactobacillus reuteri as an adjunct to non‐surgical periodontal therapy in chronic periodontitis. Journal of periodontology. 2015;86(6):746-54.
• 50. Riccia DD, Bizzini F, Perilli M, Polimeni A, Trinchieri V, Amicosante G, et al. Anti‐inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease. Oral diseases. 2007;13(4):376-85.
• 51. Tekce M, Ince G, Gursoy H, Dirikan Ipci S, Cakar G, Kadir T, et al. Clinical and microbiological effects of probiotic lozenges in the treatment of chronic periodontitis: a 1‐year follow‐up study. Journal of clinical periodontology. 2015;42(4):363-72.
• 52. Vivekananda M, Vandana K, Bhat K. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial. Journal of Oral Microbiology. 2010;2(1):5344.
• 53. Laleman I, Yilmaz E, Ozcelik O, Haytac C, Pauwels M, Herrero ER, et al. The effect of a streptococci containing probiotic in periodontal therapy: a randomized controlled trial. Journal of clinical periodontology. 2015;42(11):1032-41.
• 54. Teughels W, Loozen G, Quirynen M. Do probiotics offer opportunities to manipulate the periodontal oral microbiota? Journal of Clinical Periodontology. 2011;38:159-77.
• 55. Shah MP, Gujjari SK, Chandrasekhar VS. Evaluation of the effect of probiotic (Inersan®) alone, combination of probiotic with doxycycline and doxycycline alone on aggressive periodontitis–a clinical and microbiological study. Journal of clinical and diagnostic research: JCDR. 2013;7(3):595.